
Sign up to save your podcasts
Or
As COVID-19 spreads globally, populations who survive their illness will become immune. Mayo Vaccine Research Group Director Gregory Poland, MD, discusses antibody responses, duration of immunity, vaccine safety, and the prospects for using convalescent serum to passively immunize people unexposed to SARS-CoV-2.
4.6
162162 ratings
As COVID-19 spreads globally, populations who survive their illness will become immune. Mayo Vaccine Research Group Director Gregory Poland, MD, discusses antibody responses, duration of immunity, vaccine safety, and the prospects for using convalescent serum to passively immunize people unexposed to SARS-CoV-2.
758 Listeners
38,580 Listeners
135 Listeners
316 Listeners
21,675 Listeners
866 Listeners
498 Listeners
43,367 Listeners
6,695 Listeners
687 Listeners
3,321 Listeners
17 Listeners
18 Listeners
13 Listeners
22 Listeners
6 Listeners
90 Listeners
29 Listeners
194 Listeners
350 Listeners
6,219 Listeners
18 Listeners